IPGP vs NBIX · P/E 158, rev $977.1M vs P/E 45, rev $2.36B
IPG Photonics Corporation (IPGP) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
IPG Photonics Corporation (IPGP) is a semiconductor equipment & materials company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported IPGP revenue for 2024-12-31 was $977.1M. Net income was -$181.5M. Revenue was down 24.1% from 2023-12-31 to 2024-12-31. IPGP currently screens at market cap $4.56B and trailing P/E 157.9.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
IPGP currently screens at market cap $4.56B and trailing P/E 157.9. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the IPGP and NBIX stock pages for the full models.
Not investment advice.